In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii.

The efficacy of rifabutin (RIFA) alone or in combination with atovaquone (ATO) was examined in vitro and in a murine model of acute toxoplasmosis. In vitro studies were performed with MRC5 fibroblast tissue cultures, with quantification of Toxoplasma growth by enzyme-linked immunosorbent assay. For...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Romand, S, Della Bruna, C, Farinotti, R, Derouin, F
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1996
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163465/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8878573/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.9.2015
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!